Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
15.87
-0.34 (-2.10%)
Nov 20, 2024, 4:00 PM EST - Market closed
Tyra Biosciences Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Tyra Biosciences stock have an average target of 31, with a low estimate of 28 and a high estimate of 33. The average target predicts an increase of 95.34% from the current stock price of 15.87.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TYRA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $30 | Strong Buy | Maintains | $32 → $30 | +89.04% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +101.64% | Oct 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +101.64% | Oct 28, 2024 |
| Wedbush | Wedbush | Buy Reiterates $28 | Buy | Reiterates | $28 | +76.43% | Oct 25, 2024 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $22 → $31 | Hold → Strong Buy | Upgrades | $22 → $31 | +95.34% | Oct 18, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.56
from -1.62
EPS Next Year
-2.01
from -1.56
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 5.1M | ||
| Avg | n/a | n/a | 1.2M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.48 | -1.66 | -1.85 | ||
| Avg | -1.56 | -2.01 | -2.24 | ||
| Low | -1.58 | -2.17 | -2.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.